OnconovaTherapeuticsadmin2022-01-16T21:10:41+00:00 Project Description Confidentially Marketed Public Offering Common Stock $5,963,517 Sole Book Runner April 2017 Related Project Details Categories: confidentially-marketedPIPE Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail Related Projects